TMEM225B
Transmembrane protein 225B
Also known as: T225B_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P0DP42
- Gene
- TMEM225B
- Ensembl
- ENSG00000244219
- Chromosome
- 7
- Canonical length
- 221 aa
- Protein class
- Predicted membrane proteins
OverviewNCBI Gene
Predicted to be located in membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
221 residues, UniProt reviewed canonical sequence.
>P0DP42|TMEM225B
1 MLTLEDKDMK GFSWAIVPAL TSLGYLIILV VSIFPFWVRL TNEESHEVFF SGLFENCFNA
61 KCWKPRPLSI YIILGRVFLL SAVFLAFVTT FIMMPFASEF FPRTWKQNFV LACISFFTGA
121 CAFLALVLHA LEIKALRMKL GPLQFSVLWP YYVLGFGIFL FIVAGTICLI QEMVCPCWHL
181 LSTSQSMEED HGSLYLDNLE SLGGEPSSVQ KETQVTAETV ILocalizationUniProt · AlphaFold · HPA
Whether an antibody against TMEM225B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 4
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 132 nTPM
Expression across tissuesHPA
Tissue
- testis: 132 nTPM
- skin: 3.8 nTPM
- adipose tissue: 3.4 nTPM
- epididymis: 3.3 nTPM
- kidney: 3.1 nTPM
- breast: 3 nTPM
Single-cell type
- late primary spermatocytes: 1,154 nCPM
- early spermatids: 260 nCPM
- late spermatids: 197 nCPM
- early primary spermatocytes: 137 nCPM
- differentiating spermatogonia: 7.9 nCPM
- epididymal basal cells: 7 nCPM
Immune cell
- naive B-cell: 2.2 nTPM
- naive CD8 T-cell: 1.4 nTPM
- plasmacytoid DC: 1.4 nTPM
- eosinophil: 1.3 nTPM
- NK-cell: 1.3 nTPM
- MAIT T-cell: 1.1 nTPM
Brain region
- white matter: 3 nTPM
- medulla oblongata: 2.6 nTPM
- cerebral cortex: 2.3 nTPM
- hypothalamus: 2.3 nTPM
- basal ganglia: 2.2 nTPM
- pons: 2.2 nTPM
OntologyGO
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TMEM225B as an antibody target. Whether an autoantibody or antibody against TMEM225B could matter depends on whether native TMEM225B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TMEM225B is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TMEM225B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...